412 related articles for article (PubMed ID: 26332959)
1. Clinical translation of stem cell transplantation in Parkinson's disease.
Lindvall O
J Intern Med; 2016 Jan; 279(1):30-40. PubMed ID: 26332959
[TBL] [Abstract][Full Text] [Related]
2. Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice.
Cui YF; Hargus G; Xu JC; Schmid JS; Shen YQ; Glatzel M; Schachner M; Bernreuther C
Brain; 2010 Jan; 133(Pt 1):189-204. PubMed ID: 19995872
[TBL] [Abstract][Full Text] [Related]
3. Stem cell-based therapy for Parkinson's disease.
Correia AS; Anisimov SV; Li JY; Brundin P
Ann Med; 2005; 37(7):487-98. PubMed ID: 16278162
[TBL] [Abstract][Full Text] [Related]
4. Prospects of stem cell therapy for replacing dopamine neurons in Parkinson's disease.
Lindvall O; Kokaia Z
Trends Pharmacol Sci; 2009 May; 30(5):260-7. PubMed ID: 19362379
[TBL] [Abstract][Full Text] [Related]
5. Toward full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease by stem cells.
Isacson O; Bjorklund LM; Schumacher JM
Ann Neurol; 2003; 53 Suppl 3():S135-46; discussion S146-8. PubMed ID: 12666105
[TBL] [Abstract][Full Text] [Related]
6. Stem cells for cell therapy in Parkinson's disease.
Lindvall O
Pharmacol Res; 2003 Apr; 47(4):279-87. PubMed ID: 12644384
[TBL] [Abstract][Full Text] [Related]
7. Anatomical and functional reconstruction of the nigrostriatal pathway by intranigral transplants.
Gaillard A; Decressac M; Frappé I; Fernagut PO; Prestoz L; Besnard S; Jaber M
Neurobiol Dis; 2009 Sep; 35(3):477-88. PubMed ID: 19616502
[TBL] [Abstract][Full Text] [Related]
8. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
During MJ; Kaplitt MG; Stern MB; Eidelberg D
Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
[TBL] [Abstract][Full Text] [Related]
9. Long term behavioral effects of functional dopaminergic neurons generated from human neural stem cells in the rat 6-OH-DA Parkinson's disease model. Effects of the forced expression of BCL-X(L).
Ramos-Moreno T; Castillo CG; Martínez-Serrano A
Behav Brain Res; 2012 Jun; 232(1):225-32. PubMed ID: 22537773
[TBL] [Abstract][Full Text] [Related]
10. Autologous neural stem cell transplantation: a new treatment option for Parkinson's disease?
Arias-Carrión O; Yuan TF
Med Hypotheses; 2009 Nov; 73(5):757-9. PubMed ID: 19467573
[TBL] [Abstract][Full Text] [Related]
11. Stem cell treatment for Parkinson's disease: an update for 2005.
Snyder BJ; Olanow CW
Curr Opin Neurol; 2005 Aug; 18(4):376-85. PubMed ID: 16003112
[TBL] [Abstract][Full Text] [Related]
12. Cell-based therapies for Parkinson's disease.
Dyson SC; Barker RA
Expert Rev Neurother; 2011 Jun; 11(6):831-44. PubMed ID: 21651331
[TBL] [Abstract][Full Text] [Related]
13. [Cell therapy for Parkinson's disease: I. Embryonic and adult donor tissue transplantation].
Anisimov SV
Adv Gerontol; 2008; 21(4):575-92. PubMed ID: 19432209
[TBL] [Abstract][Full Text] [Related]
14. Regenerative medicine in Parkinson's disease: generation of mesencephalic dopaminergic cells from embryonic stem cells.
Taylor H; Minger SL
Curr Opin Biotechnol; 2005 Oct; 16(5):487-92. PubMed ID: 16143504
[TBL] [Abstract][Full Text] [Related]
15. Embryonic and adult stem cells as a source for cell therapy in Parkinson's disease.
Levy YS; Stroomza M; Melamed E; Offen D
J Mol Neurosci; 2004; 24(3):353-86. PubMed ID: 15655260
[TBL] [Abstract][Full Text] [Related]
16. Dopaminergic differentiation using pluripotent stem cells.
Momčilović O; Montoya-Sack J; Zeng X
J Cell Biochem; 2012 Dec; 113(12):3610-9. PubMed ID: 22807388
[TBL] [Abstract][Full Text] [Related]
17. Cell replacement therapy for Parkinson's disease.
Wijeyekoon R; Barker RA
Biochim Biophys Acta; 2009 Jul; 1792(7):688-702. PubMed ID: 19007882
[TBL] [Abstract][Full Text] [Related]
18. Neural transplantation: a hope for patients with Parkinson's disease.
Lindvall O
Neuroreport; 1997 Sep; 8(14):iii-x. PubMed ID: 9331903
[TBL] [Abstract][Full Text] [Related]
19. [Cell therapy for Parkinson's disease: II. Somatic stem cell-based applications].
Anisimov SV
Adv Gerontol; 2009; 22(1):150-66. PubMed ID: 19827685
[TBL] [Abstract][Full Text] [Related]
20. [Cell therapy for Parkinson's disease: III. Neonatal, fetal and embryonic stem cell-based applications].
Anisimov SV
Adv Gerontol; 2009; 22(2):296-315. PubMed ID: 19947394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
